Lemonade (NYSE:LMND) Given New $53.00 Price Target at Morgan Stanley

Lemonade (NYSE:LMND) had its target price boosted by Morgan Stanley from $49.00 to $53.00 in a research report released on Monday morning, Marketbeat.com reports. Morgan Stanley currently has an underweight rating on the stock.

Other equities research analysts have also recently issued reports about the company. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Lemonade in a report on Wednesday, October 8th. Piper Sandler reduced their price objective on Lemonade from $60.00 to $55.00 and set a “neutral” rating on the stock in a research note on Friday, October 10th. BMO Capital Markets upped their price objective on Lemonade from $23.00 to $42.00 and gave the stock an “underperform” rating in a report on Monday, August 18th. Cantor Fitzgerald upgraded Lemonade to a “strong-buy” rating in a research report on Wednesday, August 13th. Finally, Wall Street Zen upgraded shares of Lemonade from a “sell” rating to a “hold” rating in a research report on Saturday, August 9th. One research analyst has rated the stock with a Strong Buy rating, one has given a Buy rating, one has given a Hold rating and four have issued a Sell rating to the company. According to MarketBeat.com, Lemonade presently has an average rating of “Reduce” and an average price target of $49.33.

Lemonade Stock Performance

Shares of NYSE:LMND opened at $67.18 on Monday. The firm has a fifty day moving average price of $57.88 and a 200 day moving average price of $47.55. Lemonade has a fifty-two week low of $24.31 and a fifty-two week high of $83.77. The firm has a market cap of $5.02 billion, a price-to-earnings ratio of -28.11 and a beta of 2.26.

Lemonade (NYSE:LMND) last announced its quarterly earnings results on Wednesday, November 5th. The company reported ($0.51) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.72) by $0.21. The company had revenue of $194.50 million for the quarter, compared to the consensus estimate of $185.06 million. Lemonade had a negative net margin of 26.39% and a negative return on equity of 31.86%. Lemonade’s revenue for the quarter was up 42.4% compared to the same quarter last year. During the same period in the previous year, the firm posted ($0.95) EPS. Lemonade has set its Q4 2025 guidance at EPS. FY 2025 guidance at EPS. As a group, research analysts predict that Lemonade will post -3.03 earnings per share for the current year.

Insider Buying and Selling at Lemonade

In related news, COO Adina Eckstein sold 5,988 shares of the firm’s stock in a transaction on Monday, November 10th. The stock was sold at an average price of $78.00, for a total value of $467,064.00. Following the completion of the sale, the chief operating officer directly owned 227,987 shares in the company, valued at $17,782,986. This trade represents a 2.56% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, insider John Sheldon Peters sold 2,718 shares of Lemonade stock in a transaction on Wednesday, September 3rd. The stock was sold at an average price of $50.34, for a total transaction of $136,824.12. Following the transaction, the insider directly owned 102,397 shares of the company’s stock, valued at $5,154,664.98. The trade was a 2.59% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold a total of 48,988 shares of company stock worth $3,538,884 in the last 90 days. 12.50% of the stock is currently owned by insiders.

Hedge Funds Weigh In On Lemonade

Several hedge funds have recently added to or reduced their stakes in LMND. CANADA LIFE ASSURANCE Co lifted its stake in Lemonade by 11.6% in the third quarter. CANADA LIFE ASSURANCE Co now owns 17,769 shares of the company’s stock worth $966,000 after purchasing an additional 1,844 shares during the last quarter. Worth Venture Partners LLC purchased a new stake in shares of Lemonade in the third quarter worth approximately $297,000. PharVision Advisers LLC purchased a new stake in shares of Lemonade in the third quarter worth approximately $214,000. Voleon Capital Management LP bought a new stake in shares of Lemonade during the 3rd quarter worth approximately $561,000. Finally, Scientech Research LLC bought a new stake in shares of Lemonade during the 3rd quarter worth approximately $440,000. 80.30% of the stock is currently owned by institutional investors.

Lemonade Company Profile

Lemonade, Inc provides various insurance products through various channels in the United States, Europe, and the United Kingdom. Its insurance products include stolen or damaged property, and personal liability that protects its customers if they are responsible for an accident or damage to another person or their property.